Comments*

 
  • Events 

    Tuesday, March 24, 2015 | 11:45 AM - 4:00 PM

    Positive Allosteric Modulators for Challenging GPCRs: Identification and Optimization

    Speakers: P. Jeffrey Conn (Vanderbilt University), Ron Dror (Stanford University), Christopher Fotsch (Amgen), Corey Hopkins (Vanderbilt University), Whitney Nolte (Pfizer)

    In this symposium, academic and industry scientists will describe the identification, characterization, and development of PAMs for challenging GPCRs.

    March 26 - 27, 2015

    The Role of Nutrition in Dementia Prevention and Management

    Keynote Speakers: Miia Kivipelto (Karolinska Institutet), Irwin H. Rosenberg (Tufts University), A. David Smith (University of Oxford)
    Speakers: Cédric Annweiler (Angers University Hospital), Stephen Cunnane (Université de Sherbrooke), Agnes Flöel (Charité - University Medicine Berlin), Gary E. Gibson (Weill Cornell Medical College, Burke Medical Research Institute), Richard S. Isaacson (Weill Cornell Medical College, New York-Presbyterian Hospital), Heather H. Keller (University of Waterloo), Max Lugavere (Independent Documentary Filmmaker), Joshua W. Miller (Rutgers, The State University of New Jersey), Martha Clare Morris (Rush University), Suzana Petanceska (National Institute on Aging), Helga Refsum (University of Oslo, Norway), Kirsten Tillisch (David Geffen School of Medicine at UCLA), Katherine L. Tucker (University of Massachusetts, Lowell), Natalia Wagemans (Nestlé Nutrition Institute)

    This conference will discuss issues of epidemiological perspectives and the role of nutrition in dementia prevention and management.

    Monday, April 6, 2015 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Jef Boeke (NYU Langone Medical Center), Mike Glickman (Memorial Sloan-Kettering Cancer Center), Eric Greene (Columbia University Medical Center), Evgeny Nudler (NYU Langone Medical Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, April 7, 2015 | 8:30 AM - 4:30 PM

    Cytokine-Based Immunotherapies

    Keynote Speaker: James W. Mier (Beth Israel Deaconess Medical Center/ Harvard Medical School, Boston, MA)
    Speakers: Stephen D. Gillies (Provenance Biopharmaceuticals, Carlisle, MA), Jerome Ritz (Harvard Medical School), Gilles Uzé (Université Montpellier II, Montpellier, France), K. Dane Wittrup (Massachusetts Institute of Technology, Cambridge, MA)

    Systemic toxicity currently prevents exploiting the potential of many cytokines to treat cancer, viral infections, inflammatory and autoimmune conditions. Targeted delivery of immune-stimulatory or immune-regulatory cytokines offers much promise.

    Thursday, April 16, 2015 | 8:00 AM - 7:00 PM

    Nutrition and the Science of Disease Prevention: A Systems Approach to Support Metabolic Health

    Speakers: Brian Bennett (University of North Carolina), Kevin Hall (National Institute of Health), Frank Hu (Harvard School of Public Health), Rudolph Leibel (Columbia University), Anne McCartney (University of Reading), Christina A. Roberto (Harvard T.H. Chan School of Public Health)

    This one-day conference will highlight the connection between nutrition and the complex science of preventing disease. Speakers will focus on promotion of optimal metabolic health, building on input from several complementary disciplines.

  • Past Events

    Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM

    Harnessing the Potential of Genome Editing for Drug Discovery: Translational Frontiers of in vitro and in vivo Applications

    Speakers: Chad Cowan (Harvard University), James Inglese (National Center for Advancing Translational Sciences, NIH), J. Keith Joung (Massachusetts General Hospital), Randall Platt (Massachusetts Institute of Technology), Yi Yang (Novartis Institutes for Biomedical Research), Lei (Stanley) Qi (University of California San Francisco)

    The emergence of genome editing technologies such as TALEN and CRISPR/Cas9 are revolutionizing our ability to rapidly engineer mammalian systems. This symposium explores the frontiers of genome editing and potential to aid therapeutic development.

    Monday, February 2, 2015 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Prasad Jallepalli (Memorial Sloan-Kettering Cancer Center), Shelley Berger (University of Pennsylvania), Iestyn Whitehouse (Memorial Sloan-Kettering Cancer Center), John Petrini (Memorial Sloan-Kettering Cancer Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Thursday, January 29, 2015 | 6:30 PM - 8:00 PM

    Non-Traditional Postdocs

    Speakers: Susan D. Croll (Associate Director, Pain, Addiction & Neurology Postdoctoral Program Director Regeneron Pharmaceuticals), Uzi de Haan (Director of Entrepreneur Postdoc Program at Cornell Tech), Karen Hanson Widbin (Manager of Postdoctoral Program Operations)

    Join the Science Alliance (NYAS) as we discuss the non-traditional postdoc's alternatives. Topics will include differences between academia and industry, hiring and transition mechanisms, salaries and challenges.

    Wednesday, January 21, 2015 | 8:30 AM - 4:00 PM

    The New York Structural Biology Discussion Group 10th Winter Meeting

    Speakers: Jasna Brujic (New York University), Bridget Carragher, John Chodera, Oliver Clarke, Erik Debler, Nancy Greenbaum, David Hall, Barry Honig, Jinrang Kim (Columbia University), Nina Liu (Albert Einstein College of Medicine), Patrick Loria (Yale University), Sean McSweeney (Brookhaven National Lab), Clint Potter

    The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.

  • Publications 

    eBriefing

    Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges

    Organizers: Magdalena Alonso-Galicia (MAG Pharma Consulting LLC), Ken Jones (Allergan), Scott MacDonnell (Boehringer Ingelheim Pharmaceuticals), and Jennifer Henry (formerly at The New York Academy of Sciences)

    This eBriefing reviews targets for preventive or therapeutic interventions in diabetic kidney disease and discusses clinical development.

    eBriefing

    Innovative Funding Models for Alzheimer's Disease and Dementia

    Organizers: Cynthia Duggan (The New York Academy of Sciences), Maike Stenull (Johnson & Johnson), and George Vradenburg (Global CEO Initiative on Alzheimer's Disease)
    Keynote Speaker: Dennis Gillings (World Dementia Council)

    This eBriefing explores new public and private funding mechanisms to meet the challenges of financing AD research and care.

    Annals

    Building the Knowledge Base for Climate Resiliency: New York City Panel on Climate Change 2015 Report

    Cynthia Rosenzweig and William Solecki, Editors

    Increasing resiliency of New York City to a range of climate risks in the coming decades

    eBriefing

    Food Safety Considerations for Nutrition Science

    Keynote Speakers: Robert E. Brackett (Illinois Institute of Technology) and Frank Yiannas (Wal-Mart Stores Inc.)

    This eBriefing considers issues of food security, economics, policy, and communication related to food safety.

  • Podcasts

    Podcast
    April 14, 2011

    The Diabetes-Gum Disease Connection

    Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.

    Download (11 MB, 13:03)
    Podcast
    September 10, 2010

    What Makes Us Wise?

    Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.

    Download (22 MB, 00:42:32)
    Podcast
    August 27, 2010

    Better Brains

    Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.

    Download (35 MB, 00:54:21)
    Podcast
    August 13, 2010

    How Prosperity Evolves

    With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.

    Download (33 MB, 00:51:28)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

    Webinar Archive
    February 23, 2010

    Metabotropic Glutamate Receptors: Translation from Discovery to Clinical Trials

    Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

    Webinar Archive
    April 28, 2009

    Protein Kinases: Structure-Guided Drug Discovery

    Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.